Scleroderma is a chronic autoimmune disease characterized by fibrosis and hardening of the skin and other organs--occasionally involving the kidney to such an extent that dialysis becomes necessary. There are two main flavors of scleroderma:(1) the CREST syndrome, a localized form of the disease in which the kidney is NOT typically involved. This variant is typically anti-centromere antibody-positive. Hearkening back to your internal medicine days, you will recall that "CREST" stands for "Calcinosis, Reynaud's phenomenon, Esophageal dysmotility, Sclerodactyly, and Telangiectasias."
(2) Diffuse scleroderma, which is the type that may result in hypertension and renal involvement. These patients are more likely to be anti-SCL70 antibody-positive. The term "scleroderma renal crisis" is used to describe scleroderma patients with aggressively accelerating hypertension which may even result in renal failure. The mechanism of disease is a thrombotic microangiopathy, and urinalysis is generally bland. The mainstay of therapy for scleroderma renal crisis is blockade of the renin-angiotensin system.
No comments:
Post a Comment
Renal Fellow Network encourages comments and discussion regarding the posts. Do not post any comments that are commercial or advertising in nature. Posts will be deleted if commercial or advertising comments are made. Internet users commenting on the Renal Fellow Network must post information which is true and correct to their knowledge. Sources to health/medical claims must be provided when relevant. Moderators reserve the right to erase, without notification, any comment they would judge inappropriate.